Industry Contributions through Access Accelerated
Universal health coverage (UHC) has become an increasingly powerful common cause in global health as countries around the world seek to bring quality care to more of their populations, while protecting them from financial hardship. UHC is a cornerstone of the United Nations (UN) Sustainable Development Goals (SDGs), and as a central priority in its current general program of work, the World Health Organization (WHO) has committed to achieving UHC for 1 billion people by 2023.
The Access Accelerated approach is anchored in growing global and local momentum to achieve UHC; effectively addressing NCDs is foundational to achieving UHC and crucial to realizing the SDGs. As the growing burden of NCDs continues to put pressure on local health systems’ ability to ensure its people can access equitable, high-quality and affordable health care, Access Accelerated is mobilizing the collective capacity of the biopharmaceutical industry and its partners to address this challenge through our NCD initiatives.